Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-000988-25Phase 4Unknown
Phase 4, open-label, single-arm trial of sulfur hexafluoride in Vulval carcinoma, sponsored by Gateshead Health NHS Foundation Trust. Primary endpoint: Recruitment feasibility. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-000988-25.